Transaction DateRecipientSharesTypePriceValue
19th November 2020Louis J Jr Lavigne6,219Exercise of derivative$0.00
17th November 2020Advisors Llc Orbimed434,008Exercise of in-the-money or at-the-money derivatives securities (usually options)$0.01$4,340.08
17th November 2020Advisors Llc Orbimed765,992Exercise of in-the-money or at-the-money derivatives securities (usually options)$0.01$7,659.92
17th November 2020Advisors Llc Orbimed868,016Exercise of in-the-money or at-the-money derivatives securities (usually options)$0.01$8,680.16
17th November 2020Advisors Llc Orbimed1,531,984Exercise of in-the-money or at-the-money derivatives securities (usually options)$0.01$15,319.84
17th November 2020Advisors Llc Orbimed434,008Exercise of in-the-money or at-the-money derivatives securities (usually options)$0.01$4,340.08
17th November 2020Advisors Llc Orbimed765,992Exercise of in-the-money or at-the-money derivatives securities (usually options)$0.01$7,659.92
2nd October 2020Advisors Llc Orbimed200,000Open or private purchase$25.00$5,000,000.00
2nd October 2020Advisors Llc Orbimed296,000Open or private purchase$25.00$7,400,000.00
1st October 2020Advisors Llc Orbimed296,296Open or private purchase$6.00$1,777,776.00
Alector
Alector logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.


Alector, Inc. develops therapeutics for the treatment of neurodegenerative diseases including frontotemporal dementia (FTD), Alzheimer's disease, and Parkinson's disease. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in 2013.


Ticker: ALEC
Sector: Healthcare
Industry: Biotechnology
SEC Central Index Key (CIK): 1653087
Employees:
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals